Jordi Gibert
Head of Biotechnology Unit Klinea Biotech & Pharma Engineering
Seminars
Thursday 26th February 2026
From Breakthrough to Bedside: Why Facilities Matter in CAR‑T Access
11:30 am
- CAR‑T is a clinical success. Access is the challenge.
- In CAR‑T manufacturing, the facility is not just a GMP container
- Facilities are silent enablers. Engineering decisions directly affect CAR-T outcomes.
